Zimmermann, Astrid,Damstrup, Lars,Prokein, Anne-Kathrin,Schroeder, Andreas
申请号：
AU2018241774
公开号：
AU2018241774A1
申请日:
2018.03.27
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises an anti-PD-L antibody and a DNA-PK inhibitor, optionally together with one or more additional chemotherapeutic agents or radiotherapy. The therapeutic combination is particularly intended for use in treating a subject having a cancer that tests positive for PD-L1 expression.
